Attune Medical

As HRS 2024 concludes, we’re taking a moment to reflect on the highlights that made this year's event truly impactful:

-Partnership Power: Together with Haemonetics®, we showcased how collaboration makes us stronger together. We make it possible. You make it matter.
-Skills Workshops: A huge thank you to our attendees and expert faculty for making these sessions a dynamic hub of hands-on learning.
-Impactful Presentations: Our Rhythm Theater sessions and numerous posters put a spotlight on ensoETM® and its potential in RF cardiac ablations.
-Engaging Interactions: Your involvement at our booths provided invaluable feedback and propelled innovative thinking in electrophysiology.

We are deeply grateful to everyone who contributed to this enriching experience.

Missed us at the event or want to learn more? Connect with us at [email protected]! 📧

We’re pleased to share that the ensoETM® has been featured in the latest EHRA/HRS/APHRS/LAHRS expert consensus statement on catheter and surgical ablation of atrial fibrillation. It's always rewarding to see discussion of proactive esophageal cooling™ in RF cardiac ablations. Let's continue to spread the word and keep the momentum going!

For more data on esophageal cooling with ensoETM, visit our website or read the full statement here: https://www.heartrhythmjournal.com/article/S1547-5271(24)00261-3/fulltext

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on catheter and surgical ablation of atrial fibrillation Document Reviewers: Daniel Steven (Reviewer Coordinator), Michael-Joseph Agbayani, T. Jared Bunch, Aman Chugh, Juan Carlos Díaz, James V. Freeman, Carina Abigail Hardy, Hein Heidbuchel, Sofian Johar, Dominik Linz, Bart Maesen, Peter A. Noseworthy, Seil Oh, Andreu Porta-Sanchez, Tatjana Potpara, Ger...

Haven’t seen us at yet? There’s still time!

Visit Attune Medical® at booth #1163 and Haemonetics® at booth #563 to discover the impact ensoETM® can have on your procedures.

Don't miss this chance! Swing by for a friendly conversation and to learn about proactive esophageal cooling™ for your RF cardiac ablations.

On your way to ?

You'll have ample opportunity to explore how proactive esophageal cooling™ with ensoETM® impacts RF cardiac ablations. We can't wait to see you in Boston and look forward to an exceptional conference. Make sure to visit us at the Attune Medical® and Haemonetics® booths!

📍 Attune Medical: Booth #1163
📍 Haemonetics: Booth #563

To book a time with us or to see what we have planned, visit: https://pulse.ly/qyetsgxv1p

We'll see you there!

Don't miss our Rhythm Theater session at HRS this Saturday, May 18th!

Join us to hear from leading experts about clinical experiences with ensoETM® for esophageal cooling during RF cardiac ablation and VASCADE MVP® for venous vascular closure, highlighting the clinical and economic value of early ambulation and same-day discharge.

📅 Secure your spot now and mark your calendars! For more information: https://pulse.ly/y4nven7ggf

Headed to next month? Don't miss out! Register now for our enlightening skills workshop.

Here's what to expect:

• Exclusive Meet-and-Greet: Engage with fellow professionals and broaden your network in the field.
• Interactive Demo: Experience the ensoETM® firsthand and discover its impact on RF cardiac ablations.
• In-Depth Learning: Dive into the science behind proactive esophageal cooling™ and its impact on patient care.
• Clinical Insights: Explore the latest clinical data showcasing ensoETM®'s effectiveness and safety.

Looking forward to seeing you there. Make sure to email [email protected] and let us know you're coming!

Concerned that proactive esophageal cooling™ might affect your lesion sets during RF cardiac ablations? Let's put those worries to rest.

The innovative cooling mechanism of the ensoETM® precisely protects the esophagus without compromising the efficacy of your lesions. A critical study using an in silico model for high-power short-duration (HPSD) ablation revealed: Even with proactive cooling, atrial lesions maintained 100% transmurality, and the impact on lesion width was negligible (< 0.8 mm).

In addition to what we've seen in clinical practice, these results demonstrate the ensoETM’s capability to enhance patient safety during ablations; without negatively affecting procedural outcomes.

Dive deeper into the full study to learn more: https://www.tandfonline.com/doi/full/10.1080/02656736.2022.2121860

Results from the 25-center study involving over 25,000 patients comparing the incidence of atrioesophageal fistulas (AEFs) - a highly serious and often fatal complication associated with RF cardiac ablations - before and after the implementation of proactive esophageal cooling™.

What did the expert commentary by Douglas Kyrouac, MD, and James Daniels, MD, on PracticeUpdate say about it?

"Based on this study, there appears to be a potentially significant beneficial effect to using esophageal cooling to avoid serious adverse complications with a minimal downside—an estimated 30-fold decreased risk of AEF compared with the current standard of care... Our center began using esophageal cooling more than 3 years ago, and we have reported additional patient and procedural advantages."

See the full article by visiting: https://www.sciencedirect.com/science/article/pii/S2405500X23006734?via%3Dihub